Evaluation of method of measuring serum insulin glargine concentration after subcutaneous administration of insulin glargine in healthy male subjects. - Evaluation of method of measuring serum insulin glargine concentration

Medical Co. LTA, Clinical Pharmacology Center0 个研究点目标入组 6 人开始时间: 2012年12月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1, Subjects with present illness which requires treatment. 2, Subjects with past medical history which was considered not adequate for this study. 3, Subjects with past history of drug allergy. 4, Subjects who took prescribed medicine and/or OTC drug 1 week prior to admission to the clinic. 5. Subjects who donated and/or withdrawn whole blood more than 400mL within 12 weeks, 200mL within 4 weeks, and/or blood component within 2 weeks prior to admission. 6, Subjects who were participated in a clinical trial and administered new compound study drug within 4 weeks, or any kind of study drug within 3 weeks prior to admission. 7, Subjects with history of alcohol and/or drug abuse. 8, Subjects who was judged not appropriate for this study by study physician.

发起方

Medical Co. LTA, Clinical Pharmacology Center